Today Santhera announced that they have received a negative opinion on the Appeal for Authorization of Raxone®…Continue
Added by PPMD on January 26, 2018 at 10:00am — No Comments
Today, Summit announced positive 24-week interim data from PhaseOut DMD, their Phase 2 clinical trial of the utrophin modulator ezutromid.…Continue
Added by PPMD on January 25, 2018 at 10:00am — No Comments
Parent Project Muscular Dystrophy believes in the promise that gene therapy holds for the Duchenne community. And so we set an ambitious fundraising goal for our Gene Therapy Initiative. In fact, $500,000 is our largest fundraising goal ever.
Added by PPMD on January 3, 2018 at 9:30am — No Comments